Home / Health / Weight Drugs Cut Alcohol Hospital Trips
Weight Drugs Cut Alcohol Hospital Trips
22 Jul
Summary
- Weight loss drugs may significantly reduce hospital admissions for alcohol dependence.
- GLP-1 receptor agonists show potential for treating alcohol-use disorder.
- Studies suggest these drugs offer broader health benefits beyond weight loss.
Weight loss medications such as Wegovy and Mounjaro are showing promise in reducing hospitalizations among individuals with alcohol dependence. A comprehensive study involving 41,000 users found that those on these powerful appetite-suppressing drugs were approximately two-thirds less likely to need hospital care.
Researchers are exploring GLP-1 receptor agonists, which mimic the fullness hormone, as potential treatments for addiction. Previous research indicated these drugs could reduce alcohol cravings and the number of drinks consumed per session.
Analysis of multiple studies revealed that GLP-1 drugs decreased the risk of alcohol-related hospital admissions by 26% compared to other diabetes medications. For those using the drugs for weight loss, the risk was 32% lower than with other obesity treatments.
While these findings, published in BMJ Open, suggest a potential role for GLP-1 medications, experts emphasize the need for further research. They note that observational studies, particularly from the US, may have confounding factors like patient affluence and access to care influencing the results.
